期刊文献+

中西医结合治疗重症肺炎气虚痰阻型临床观察 被引量:1

Clinical Observation on Severe Pneumonia with Phlegm Obstruction due to Lung-deficiency Type Treated by Combination of TCM and Western Medicine
下载PDF
导出
摘要 目的:观察中西医结合治疗重症肺炎气虚痰阻型的临床疗效。方法:60例随机分成试验组及对照组各30例。试验组予中医益气化痰法联合西医治疗,对照组单用西医治疗,连续治疗7天,比较两组治疗前后临床证候积分、疗效、PCT及sTREM-1等指标。结果:总有效率试验组高于对照组(P<0.05)。结论:中西医结合治疗重症肺炎气虚痰阻型疗效较好。 Objective : To observe the clinical therapeutic effect of combination of TCM and western medicine in the treatment of severe pneumonia with Qi deficiency and phlegm resistance. Method : a total of 60 cases of severe pneumonia with Qi deficiency and phlegm retention type were randomly divided into the experimental group and the control group, 30 cases in each group. The experimental group were treated with traditional Chinese medicine combined with western medicine while the control group were treated with single use of conventional western medicine. Both groups were continuously treated for 7 days. The clinical symptom score, curative effect, PCT and sTREM-1 in two groups before and after treatment were compared. Result: The total effective rate of the treatment group was higher than that of the control group ( P〈0.05 ) .Conclusion : Combination of TCM and western medicine has good therapeutic effect on severe pneumonia with Qi deficiency and phlegm resistance.
出处 《实用中医药杂志》 2018年第4期431-433,共3页 Journal of Practical Traditional Chinese Medicine
基金 广东省广州市医药卫生科技项目课题(20162A011029)
关键词 重症肺炎 气虚痰阻型 中西医结合 对照治疗观察 Severe pneumonia Qi deficiency and phlegm resistance Combination of TCM and observation Control treatment and observation
  • 相关文献

二级参考文献24

  • 1杨德治,毕庆和,丁霭玲,应崇智.黄芪对小肠电活动的影响[J].中国中西医结合杂志,1993,13(10):616-617. 被引量:44
  • 2Zi-Qing Hei,He-Qing Huang,Jing-Jun Zhang,Bing-Xue Chen,Xiao-Yun Li.Protective effect of Astragalus membranaceus on intestinal mucosa reperfusion injury after hemorrhagic shock in rats[J].World Journal of Gastroenterology,2005,11(32):4986-4991. 被引量:9
  • 3Femandez-Serrano S, Dorca J, Coromines M, et al. Molecular inflammatory responsesmeasured in blood of patients with severe community-acquired pneumonia. ClinDiagn Lab Immunol, 2003, 10 (5) :813-820.
  • 4Park WY, C, oodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patientswith acute respiratory distress syndrome. Am J Bespir Crit Care Med ,2001,164 : 1896-1903.
  • 5American Thoracic Society Guidelines for the Management of Adults withConununity-acquired Pneumonia Diagnosis, Assessment of Severity, Antimicrobial, Therapy, and Prevention. Am J Respir Crit Care Med, 2001,163:1730-1754.
  • 6Monton C, Torres A, EI-Ebiary M, et al. Cytokine expression in severe pneumonia: Abronchoalveolar lavage study. Crit Care Med , 1999, 27:1745 -1753.
  • 7Hitoshi W. Daisuke I. Masao N. Clinical Evaluation of Circulating Interleukin-6 andInterleukin-10 Levels after Surgery-induced Inilammarion. Journal of SurgicalResearch, 2005, 125:144-150.
  • 8Luna CM, Blanzaco D, Niederman MS. Resolution of ventilator-associated pneumonia:prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med, 2003,31 (3) :676-682.
  • 9Antunes G, Evans SA, Lordan JL, et al. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir , 2002,20(4) : 990-995.
  • 10Maus U, Rosseau S, Knies U, et al. Expression of pro-inflammatory cytokines byflow-sorted alveolar macrophages in severe pneumonia. Eur Respir J, 1998,11 (3) :534-541.

共引文献68

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部